🇺🇸 FDA
Patent

US 11844867

Method of delivering insulin into a lumen of the intestinal tract using a swallowable drug delivery device

granted A61KA61K38/26A61K38/28

Quick answer

US patent 11844867 (Method of delivering insulin into a lumen of the intestinal tract using a swallowable drug delivery device) held by Rani Therapeutics, LLC expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K38/26, A61K38/28, A61K45/06, A61K9/0053